William Blair says Aspira is a show-me story, resumes with 'market perform' rating

Aspira Women's Health

02/09/2022 14:46

** William Blair says Aspira Women's Health Inc  AWH.O  is
show-me story at this point with investors waiting to see
success before building position as it resumes coverage with
"market perform" rating 
    ** Brokerage suspended rating in May, citing financial
overhang due to slower-than-anticipated revenue ramp-up and cash
burn; Last week AWH raised $9 mln in public offering 
    ** Uncertain near-term outlook for AWH will likely prohibit
investors from focusing on what could be a better longer-term
story - William Blair   
    ** Brokerage keen on seeing AWH's experimental pelvic pain
therapy EndoCheck that can prove a game-changer for the stock
and patients
    ** William Blair cautions that it is difficult to see a
near-term acceleration of revenues until there is definitive
proof that the company is able to launch these new products with
sufficient clinical adoption 
    ** Up to Thursday's close, stock had fallen ~70% YTD
    
  
  

 (Reporting by Pratik Jain)
 ((Pratik.Jain@thomsonreuters.com;))